A Scoping Review on COVID-19-Induced Cardiovascular Complications
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a type of human coronavirus that resulted in the 2019 coronavirus disease (COVID-19). Although it was generally categorized as a respiratory disease, its involvement in cardiovascular complications was identified from the onset. Elevate...
Main Authors: | Ian Osoro, Manisha Vohra, Mohammad Amir, Puneet Kumar, Amit Sharma |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-03-01
|
Series: | COVID |
Subjects: | |
Online Access: | https://www.mdpi.com/2673-8112/3/3/26 |
Similar Items
-
Direct mechanisms of SARS-CoV-2-induced cardiomyocyte damage: an update
by: Yicheng Yang, et al.
Published: (2022-06-01) -
SARS-CoV-2 and its impact on the cardiovascular and digestive systems – The interplay between new virus variants and human cells
by: Angelika Szpulak, et al.
Published: (2023-01-01) -
Trends and characteristics of COVID-19 and cardiovascular disease related studies
by: Ao Cheng, et al.
Published: (2023-04-01) -
Coronavirus disease 2019 and cardiovascular system: A narrative review
by: Felix Kwenandar, et al.
Published: (2020-08-01) -
SARS-CoV-2, ACE2, and Hydroxychloroquine: Cardiovascular Complications, Therapeutics, and Clinical Readouts in the Current Settings
by: Rajkumar Singh Kalra, et al.
Published: (2020-07-01)